PrEP decision-making counseling for women in sexual health clinics
Part of Infections clinical trials.
This study tests a counseling program to help women decide whether to use PrEP (a daily pill that prevents HIV). It aims to make PrEP choices easier and more informed in sexual and reproductive health clinics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman
- You are 18 years or older
- You have a uterus (have not had a hysterectomy)
- You do not have HIV (based on what you know)
- You are not currently taking PrEP
- You can converse comfortably in English or Spanish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks people who may use PrEP—an HIV prevention medicine—about their decision to start, not start, or stop PrEP. It aims to understand needs and barriers so PrEP can work better for cisgender women and transgender people who are considering it.
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
This trial tests a program to help women who have had contact with the criminal legal system or child protective services get and stay on PrEP (a daily pill that prevents HIV). The study also looks at how to support women who have experienced intimate partner violence or risky drinking.
This trial tests a decision support tool that helps emergency department patients learn about PrEP (a daily pill that prevents HIV). It is for people who are HIV negative and not already taking HIV prevention medicine.
This trial tests a program where HIV testing counselors help family planning patients learn about and get PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to access in clinics you may already visit.
This research tests a tool that helps women and their partners make informed decisions about PrEP (a daily pill that prevents HIV). The study involves healthcare workers, patients, and leaders in Uganda to improve how women choose and use HIV prevention.
Hear when a new Reproductive Health trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.